spacer
home > pmps > Winter 2011
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Winter 2011

   
Text
PDF
Industry Insight 
To celebrate PMPS’ 50th issue,Accenture Partner and PMPS Editor Bruce Horton provides an analysis of the industry’s progress since the first edition was published in 1998, and considers where we stand now and the developments that lie ahead.  
view
download pdf
PMPS has seen a wealth of progress in the pharmaceutical world, as well as the full spectrum of economic change and huge strides in R&D.We ask leaders in key sectors to give their views on the future of the industry.
 
view
download pdf
bullet
Manufacturing
Mark Jennings at Dawson Shanahan Ltd introduces coldforming – a technique that can unlock faster and cheaper drug delivery device production – and offers a straightforward means of regulatory compliance.
 
view
download pdf
Andrew Barrow at Cherwell Laboratories points out the importance of an aseptic filling environment for biological products, and shows how the process should be carried out in line with GMP requirements.
 
view
download pdf
Mark Thompson and Sharon Smith at the Honeyman Group Ltd analyse the steam sterilisation process in detail and discuss how a good qualification study is of great importance when demonstrating its effectiveness.
 
view
download pdf
bullet
Cool Chain, Cargo & Logistics
Suzanne Parish at DHL makes a case for six key elements of communication in the clinical trials supply chain.
 
view
download pdf
Thermal requirements and material restrictions are essential elements of temperature-controlled packaging design, explains Alex Roskoss at Intelsius.
 
view
download pdf
Biological medicines and products present a unique set of challenges for the transporter. Federico Lupp at LifeConEx reviews the steps that must be taken to ensure a smooth journey.
 
view
download pdf
Kenneth T Lukes at Inmark Inc assesses the recent thermal test standard from ISTA and considers whether it has the potential to be a universally adopted regulation.  
view
download pdf
bullet
Drug Delivery 
Modern manufacturers, as well as the patients they serve, need much more efficient and effective delivery devices than today’s market is able to provide. Phil Lever at Cambridge Consultants picks out ways in which devices can be brought up to scratch.
 
view
download pdf
When bringing a drug delivery device into the US market, there are several considerations to tackle in order to enjoy a fruitful encounter with the patent process, as Clifford M Davidson at Davidson, Davidson & Kappel LLC shows.
 
view
download pdf
The astute drug manufacturer will assess a range of nasal, pulmonary and ophthalmic drug delivery devices to find the right vehicle for their product. Gerallt Williams at Aptar Pharma gives an overview of the various technologies and the features they offer.
 
view
download pdf
Bob Sharp and Paul Whyte at Future Injection Technologies Ltd analyse the future requirements of the NHS for injectables and identify patient behaviour as the key factor in the selection of delivery platforms.
 
view
download pdf
bullet
Labelling 
The pharmaceutical packaging and labelling industry is breaking into new territories more than ever before and with this progress comes the challenge of translation management, as Neil Gleghorn at Kallik explains.
 
view
download pdf
bullet
Packaging, Packing & Anti-Counterfeiting
Adrian Burden at Bilcare Technologies highlights potential technology combinations in today’s devicedriven marketplace, and argues that anti-counterfeiting initiatives should take advantage of the options available to ensure product security.
 
view
download pdf
Joseph Ringwood at Systech International takes a look at aggregation in product tracking, showing that it must be used in conjunction with serialisation in order to achieve a successful track and trace programme.
 
view
download pdf
Dean Chespy at Siemens Industry Automation explains how the efficiency gains offered by RFID, serialisation and ePedigree initiatives can benefit the whole industry, eliminating human failure and slashing costs as a result.  
view
download pdf
bullet
Formulations, Ingredients and Excipients
The unique, demanding requirements of protein-based biological products can throw up a range of problems during their formulation. Carsten Olbrich at Bayer Schering Pharma AG looks at how these can be overcome.  
view
download pdf
bullet
The End of the line
No matter how cool it keeps a product, a thermal packaging solution is no use if it can’t take a knock, as Richard Harrop discovers.  
view
download pdf
   
spacer
Edited by
Robert Harris
Chief Technical Officer at Juniper Pharma Services
Published quarterly in
February, May,
August and November

News and Press Releases

Sterling Pharma Solutions launches following management buyout


More info >>

White Papers

The Promise and Challenge of Adaptive Design in Oncology Trials

Medpace

Clinical oncology trials are more complex and time consuming than those in any other therapeutic area and failure rates are frustratingly high. Given the urgent need for new oncologic therapies, sponsors are eager to find more effective ways to conduct clinical research. Incorporating adaptive design methodologies into clinical trials can reduce costs and enhance efficiency while maintaining trial integrity. They can also reduce the number of patients on placebo and sub-therapeutic doses. In light of this promise, regulatory bodies have created guidelines supportive of adaptive design.
More info >>

Industry Events

7th annual Orphan Drugs and Rare Diseases UK

18-19 October 2017, Holiday Inn Kensington Forum, London

SMi Group is thrilled to present the 7th annual Orphan Drugs and Rare Diseases conference, taking place on 18th & 19th October 2017 in Central London, UK. This year’s theme will be focused towards discussing strategies for patient engagement, market access and gene therapies to enhance rare diseases and orphan drug research.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement